Editorial: Innovative Therapeutical Approaches for Hematological Malignancies Based on Molecular Targeted Therapies
Tags: XENOGRAFTS; RNA
Related Articles
- Anti-tumorigenic effect of a K-ras ribozyme against human lung cancer cell line heterotransplants in nude mice. Zhang, Y-A; Nemunaitis, J; Scanlon, K J; Tong, A W // Gene Therapy;Dec2000, Vol. 7 Issue 23, p2041
Approximately 15-30% of human non-small cell lung cancers (NSCLC) carry K-ras mutations, among which point mutations at codon 12 are the most common. This study characterizes the anti-tumor effect of an anti-K-ras ribozyme adenoviral vector (KRbz-ADV; replication-deficient, E1deleted Ad5...
- Causal reasoning identifies mechanisms of
sensitivity for a novel AKT kinase inhibitor,
GSK690693. Kumar, Rakesh; Blakemore, Stephen J.; Ellis, Catherine E.; Petricoin, III., Emanuel F.; Pratt, Dexter; Macoritto, Michael; Matthews, Andrea L.; Loureiro, Joseph J.; Elliston, Keith // BMC Genomics;2010, Vol. 11, p419
Background: Inappropriate activation of AKT signaling is a relatively common occurrence in human tumors, and can be caused by activation of components of, or by loss or decreased activity of inhibitors of, this signaling pathway. A novel, pan AKT kinase inhibitor, GSK690693, was developed in...
- Cancer Inhibition in Nude Mice After Systemic Application of U6 Promoter-Driven Short Hairpin RNAs Against PLK1. Sp�nkuch, Birgit; Matthess, Yves; Knecht, Rainald; Zimmer, Brigitte; Kaufmann, Manfred; Strebhardt, Klaus // JNCI: Journal of the National Cancer Institute;6/2/2004, Vol. 96 Issue 11, p862
Background: RNA interference initiated by small interfering RNAs effectively suppresses gene expression, but the suppression is transient, which limits the therapeutic use of this technique. Polo-like kinase 1 (PLK1) is a key cell cycle regulator that is overexpressed in various human tumors. We...
- Animal organs for human patients? Palca, Joseph // Hastings Center Report;Sep/Oct95, Vol. 25 Issue 5, p4
Discusses xenotransplantation and its moral implications. History; United States Food and Drug Administration's stance on the issue; Controversy over the Ildstad-Volberding protocol.
- Xenografts raise questions about cancer virus transfer to humans. Randal, Judith // JNCI: Journal of the National Cancer Institute;02/18/98, Vol. 90 Issue 4, p264
Presents information on xeno-transplants, highlighting the use of pigs' organs, while emphasizing two viruses which lurk in these organs. Identification of the viruses; Doctors' concerns with regarding these viruses; Reference to information from John Coffin, a doctor at the Tufts University in...
- Delivery Systems for the Direct Application of siRNAs to Induce RNA Interference (RNAi) In Vivo. Aigner, Achim // Journal of Biomedicine & Biotechnology;2006 Special Issue 3, p1
RNA interference (RNAi) is a powerful method for specific gene silencing which may also lead to promising novel therapeutic strategies. It is mediated through small interfering RNAs (siRNAs) which sequence-specifically trigger the cleavage and subsequent degradation of their target mRNA. One...
- Effect of RNA Interference on Gal Alpha 1,3 Gal Expression in PIEC Cells. Yu, Luyang; Miao, Hongsheng; Guo, Lihe // DNA & Cell Biology;Apr2005, Vol. 24 Issue 4, p235
Xenotransplantation from pigs to human beings is viewed as a potential solution for the acute organ shortage. However, consequent xenorejection induced by Gal alpha 1,3 Gal (a Gal, Gal antigen) prevents xenotransplantation from clinical application. Thus, the most attracting attempt to prevent...
- The miR-15a�miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Bonci, D�sir�e; Coppola, Valeria; Musumeci, Maria; Addario, Antonio; Giuffrida, Raffaella; Memeo, Lorenzo; D'Urso, Leonardo; Pagliuca, Alfredo; Biffoni, Mauro; Labbaye, Catherine; Bartucci, Monica; Muto, Giovanni; Peschle, Cesare; De Maria, Ruggero // Nature Medicine;Nov2008, Vol. 14 Issue 11, p1271
MicroRNAs (miRNAs) are noncoding small RNAs that repress protein translation by targeting specific messenger RNAs. miR-15a and miR-16-1 act as putative tumor suppressors by targeting the oncogene BCL2. These miRNAs form a cluster at the chromosomal region 13q14, which is frequently deleted in...
- The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Can Liu; Kelnar, Kevin; Bigang Liu; Xin Chen; Calhoun-Davis, Tammy; Hangwen Li; Patrawala, Lubna; Hong Yan; Jeter, Collene; Honorio, Sofia; Wiggins, Jason F.; Bader, Andreas G.; Fagin, Randy; Brown, David; Tang, Dean G. // Nature Medicine;Feb2011, Vol. 17 Issue 2, p211
Cancer stem cells (CSCs), or tumor-initiating cells, are involved in tumor progression and metastasis. MicroRNAs (miRNAs) regulate both normal stem cells and CSCs, and dysregulation of miRNAs has been implicated in tumorigenesis. CSCs in many tumors-including cancers of the breast, pancreas,...
